Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) EPS (Weighted Average and Diluted) (2021 - 2025)

Definitive Healthcare (DH) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with -$0.1 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 80.77% year-over-year to -$0.1, compared with a TTM value of -$1.3 through Dec 2025, up 63.17%, and an annual FY2025 reading of -$1.3, up 63.28% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.1 for Q4 2025 at Definitive Healthcare, up from -$0.18 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.1 in Q4 2022 and bottomed at -$1.81 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.38, with a median of -$0.1 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 200.0% in 2022, then tumbled 4900.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.1 in 2021, then skyrocketed by 200.0% to $0.1 in 2022, then plummeted by 170.0% to -$0.07 in 2023, then plummeted by 642.86% to -$0.52 in 2024, then surged by 80.77% to -$0.1 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for DH at -$0.1 in Q4 2025, -$0.18 in Q3 2025, and -$0.07 in Q2 2025.